Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ASML may raise its performance guidance for the second time this year? Both UBS and JPMorgan are optimistic

ASML may raise its performance guidance for the second time this year? Both UBS and JPMorgan are optimistic

金十金十2026/07/14 08:35
Show original
```htmlGolden Ten Data reported on July 14 that, according to Visible Alpha data, ASML (ASML.O) is expected to report second quarter sales of €8.83 billion (approximately $10.08 billion). This forecast falls within the company's previously provided guidance range of €8.4 billion to €9 billion and is higher than the €7.69 billion recorded in the same period last year. Noteworthy are ASML's performance guidance and market supply shortage issues. Driven by strong demand for semiconductors, ASML is expected to raise its annual sales forecast for the second time this year. UBS analysts stated that ASML may raise its guidance to the upper end of the range, or even slightly surpass it. Sandeep Deshpande of JPMorgan also commented that ASML could raise its guidance again, citing robust shipments of deep ultraviolet lithography machines. Furthermore, ASML CEO Christophe Fouquet said in April that investments in AI infrastructure are creating a situation where chip demand exceeds supply. Companies are unable to obtain enough memory and storage chips because AI demand has driven costs so high that Apple has been forced to increase the prices of some products. Executives at Micron Technology said last month that the supply shortage would continue beyond 2027. Investors will closely watch any comments ASML executives make regarding AI demand and its future trends.```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation

Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.

智通财经•2026/09/29 11:06

The United States relaxes fuel standards, significantly reducing technology costs for automakers: General Motors (GM.US) is expected to save 20.4 billion dollars, and the price per vehicle may drop by nearly 1,300 dollars.

The United States has relaxed fuel economy standards, allowing automakers to save $60.6 billions in technology costs by 2031, with the cost per vehicle expected to decrease by $1,289.

智通财经•2026/09/29 11:02